Stockscreener 앱 받기
4.74
9.47%
0.41
시간 외 거래:
4.77
0.03
+0.63%
전일 마감가:
$4.33
열려 있는:
$4.36
하루 거래량:
742.80K
Relative Volume:
1.10
시가총액:
$452.71M
수익:
$1,000.00K
순이익/손실:
$-48.81M
주가수익비율:
-6.1264
EPS:
-0.7737
순현금흐름:
$-39.95M
1주 성능:
+14.77%
1개월 성능:
-24.28%
6개월 성능:
+64.01%
1년 성능:
+387.50%
1일 변동 폭
$4.35
$4.77
1주일 범위
$4.06
$5.1023
52주 변동 폭
$0.712
$8.33
셰턱랩스 Stock (STTK) Company Profile
명칭
Shattuck Labs Inc
전화
512-900-4690
주소
500 W. 5TH STREET, AUSTIN
Compare STTK vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
STTK
Shattuck Labs Inc
|
4.74 | 442.20M | 1,000.00K | -48.81M | -39.95M | -0.7737 |
VRTX
Vertex Pharmaceuticals Inc
|
458.99 | 114.33B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
607.93 | 64.47B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
892.26 | 54.99B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
282.72 | 38.42B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
157.77 | 34.03B | 742.00K | -1.37B | -1.07B | -7.0731 |
셰턱랩스 Stock (STTK) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-27 | 개시 | Cantor Fitzgerald | Overweight |
| 2026-03-06 | 재개 | Needham | Buy |
| 2026-01-28 | 개시 | Piper Sandler | Overweight |
| 2025-12-01 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2025-09-08 | 개시 | Wedbush | Outperform |
| 2025-03-17 | 개시 | Leerink Partners | Outperform |
| 2024-10-02 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-10-02 | 다운그레이드 | Needham | Buy → Hold |
| 2024-10-01 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2024-06-17 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2022-08-31 | 개시 | BTIG Research | Buy |
| 2022-06-01 | 개시 | Citigroup | Buy |
| 2022-05-02 | 개시 | H.C. Wainwright | Buy |
| 2021-04-14 | 개시 | Berenberg | Buy |
| 2021-01-11 | 개시 | Evercore ISI | Outperform |
| 2020-11-03 | 개시 | Citigroup | Buy |
| 2020-11-03 | 개시 | Cowen | Outperform |
| 2020-11-03 | 개시 | Needham | Buy |
모두보기
셰턱랩스 주식(STTK)의 최신 뉴스
OrbiMed funds tied to Shattuck Labs (STTK) buy 1.25M pre-funded warrants - Stock Titan
OrbiMed funds add STTK pre-funded warrants in June 2026 stock offering - Stock Titan
[SCHEDULE 13D/A] Shattuck Labs, Inc. Amended Major Shareholder Report - Stock Titan
Top iBio (IBIO) Competitors 2026 - MarketBeat
Shattuck Labs drops 6%, prices $75M share raise at $4 per share - MSN
Shattuck Labs Stock (US8124231002): Valuation picture for this small-cap biotech - AD HOC NEWS
Insider Buying: Clay Siegall Acquires 62,500 Shares of Shattuck Labs Inc (STTK) - GuruFocus
Redmile funds detail 9.9% Shattuck Labs (STTK) stake and warrant activity - Stock Titan
Shattuck Labs (STTK) director Clay Siegall buys 62,500 shares at $4 - Stock Titan
Shattuck Labs secures $54.9M from warrant exercises, extends cash runway into 2029 - MSN
Shattuck Labs Launches $4.00 Underwritten Offering; 10.9M Shares, 7.9M Pre-Funded Warrants - TradingView
Shattuck Labs (NASDAQ: STTK) launches stock and pre-funded warrant offering at $4.00 - Stock Titan
Shattuck Labs (NASDAQ: STTK) raises ~$70.5M via equity and pre-funded warrants - Stock Titan
Latham & Watkins Advises on Shattuck Labs’ US$75 Million Public Offering - Legal Desire Media and Insights
STTK News | SHATTUCK LABS INC (NASDAQ:STTK) - ChartMill
Shattuck Labs launches proposed public offering of common stock - MSN
Shattuck Labs (STTK) Announces $75 Million Public Offering - GuruFocus
What's Going On With Shattuck Labs Stock Wednesday? - Benzinga
STTK Secures Financing with Offering Range Between $4.00 and $4. - GuruFocus
Shattuck Labs: 'Hold' On Phase 1 SL-325 Data And Next Stage Of Development (NASDAQ:STTK) - Seeking Alpha
Shattuck Labs Prices $75 Million Public Offering - marketscreener.com
Shattuck Labs, Inc. Announces Pricing of $75 Million Public Offering - Investing News Network
Shattuck Labs prices $75M public offering to fund biotech development. - Pluang
Shattuck Labs prices $75M public offering at $4 per share - Investing.com India
Shattuck Labs prices $75M public offering at $4 per share By Investing.com - Investing.com Australia
Shattuck Labs Prices Prefunded Warrants to Purchase Up to 7.9M Shares at Public Offering Price of $3.999 Each >STTK - Moomoo
Biotech Shattuck Labs sets terms for $75M stock, warrant sale - Stock Titan
Shattuck Labs, Inc. Announces Pricing Of $75 Million Public Offering At $4 Per Share - TradingView
Shattuck Labs, Inc. Announces Pricing of $75 Million Public Offering - Benzinga
STTK Secures Joint Book Runners for Upcoming Offering - GuruFocus
OrbiMed funds shift into pre-funded STTK warrants in Shattuck Labs (STTK) Form 4 - Stock Titan
Shattuck Labs stock falls on public offering announcement By Investing.com - Investing.com Nigeria
Shattuck Labs, Inc. Announces Proposed Public Offering - Investing News Network
Shattuck Labs commences public offering of common stock - Investing.com
Shattuck Labs commences public offering of common stock By Investing.com - Investing.com Nigeria
Shattuck Labs (STTK) offers common stock and pre-funded warrants; warrants exercise boosts cash - Stock Titan
Shattuck Labs stock falls on public offering announcement - Investing.com UK
Shattuck Labs posts positive Phase 1 SL-325 data; warrants exercise to fund operations into 2029 - TradingView
Shattuck Labs, Inc. Announces Public Offering of Common Stock and Pre-Funded Warrants - Quiver Quantitative
Shattuck Labs (NASDAQ: STTK) extends cash runway to 2029 on $54.9M warrant inflow and SL-325 data - Stock Titan
Biotech Shattuck Labs opens stock sale with option for 15% more shares - Stock Titan
Crude Oil Gains Over 1%; Motorcar Parts Of America Shares Surge After Q4 Earnings - Sahm
STTK Maintained by Citigroup -- Price Target Raised to $18.00 - GuruFocus
Shattuck Labs Announces Exercise of Outstanding Common Stock Warrants and Provides Financial Update - Investing News Network
Shattuck Labs receives $54.9M from warrant exercises By Investing.com - Investing.com Nigeria
셰턱랩스 (STTK) 재무 분석
매출
순이익
현금흐름
주당 순 이익
셰턱랩스 주식 (STTK) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Shukla Abhinav A. | Chief Technical Officer |
May 12 '26 |
Option Exercise |
3.57 |
2,032 |
7,254 |
83,290 |
| Shukla Abhinav A. | Chief Technical Officer |
May 12 '26 |
Sale |
7.01 |
2,032 |
14,244 |
81,258 |
| Pandite Arundathy N. | Chief Medical Officer |
May 12 '26 |
Sale |
6.61 |
30,000 |
198,300 |
166,219 |
2.60%
0.94%
자본화:
|
볼륨(24시간):